Patterns of p53 gene mutations in head and neck cancer: Full-length gene sequencing and results of primary radiotherapy

Clinical Cancer Research

Volumn 5, Issue 9, 1999, Pages 2455-2463

  Saunders, M Elizabeth ^a,b   MacKenzie, Robert ^c   Shipman, Rob ^b   Fransen, Edmee ^c   Gilbert, Ralph ^c   Jordan, Richard C K ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Visible Genetics Inc   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MONOCLONAL ANTIBODY; PROTEIN P21; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; GENE MUTATION; GENE SEQUENCE; HEAD AND NECK CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE;

AGED; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032874396     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Boring, C. C., Squires, T. S., and Tong, T. Cancer statistics, 1991. CA Cancer J. Clin., 41: 19-36, 1991.
2. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54: 594-606, 1993.
3. Sweeney, P. J., Haraf, D. J., Vokes, E. E., Dougherty, M., and Weichselbaum, R. R. Radiation therapy in head and neck cancer: indications and limitations. Semin. Oncol., 21: 296-303, 1994.
4. Borges, A. M., Shrikhande, S. S., and Ganesh, B. Surgical pathology of squamous carcinoma of the oral cavity: its impact on management. Semin. Surg. Oncol., 5: 310-317, 1989.
5. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., and Hong, W. K. Head and neck cancer. N. Engl. J. Med., 328: 184-194, 1993.
6. Nigor, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., and Devilee, P. Mutations in the p53 gene occur in diverse human tumor types. Nature (Lond.). 342: 705-708, 1989.
7. Greenblatt, M. S., Bennett, W. P., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
8. Prokocimer, M., and Rotter, V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood, 84: 2391-2411, 1994.
9. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
10. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
11. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
12. Gannon, J. V., Greaves, R., Iggo, R., and Lane, D. P. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J., 9: 1595-1602, 1990.
13. Hall, P. A., and Lane, D. P. p53 in tumour pathology: can we trust immunohistochemistry? Revisited. J. Pathol., 172: 1-4, 1994.
14. Calzolari, A., Chiarelli, I., Bianchi, S., Messerini, L., Gallo, O., Porfirio, and Mattiuz, P. L. Immunohistochemical vs. molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer. Am. J. Clin. Pathol., 107: 7-11, 1997.
15. Macgeoch, C., Barnes, D. M., Newton, J. A., Mohammed, S., Hodgson, S. V., Ng, M., Bishop, D. T., and Spurr, N. K. p53 protein detected by immunohistochemical staining is not always mutant. Dis. Mark., 11: 239-250, 1993.
16. Nylander, K., Nilsson, P., Mehle, C., and Roos, G. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas from the head and neck. Br. J. Cancer, 71: 826-830, 1995.
17. Sjogren, S., Inganas, M., Norberg, T., Lindgren, A., Nordgren, H., Holmberg, L., and Bergh, J. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J. Natl. Cancer Inst., 88: 173-182, 1996.
18. Ogden, G. R., Kiddie, R. A., Lunny, D. P., and Lane, D. P. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J. Pathol., 166: 389-394, 1992.
19. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R, Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
20. Brachman, D. G., Graves, D., Vokes, E., Beckett, M., Haraf, D., Montag, A., Dunphy, E, Mick, R., Yandell, D., and Weichselbaum, R. R. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res., 52: 4832-4836, 1992.
21. Casson, A. G., Mukhopadhyay, T., Cleary, K. R., Ro, J. Y., Levin, B., and Roth, J. A. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 51: 4495-4499, 1991.
22. Hartmann, A., Blaszyk, H., McGovern, R. M., Schroeder, J. J., Cunningham, J., De, V. E., Kovach, J. S., and Sommer, S. S. p53 gene mutations inside and outside exons 5-8: the patterns differ in breast and other cancers. Oncogene, 10: 681-688, 1995.
23. Bergh, J., Norberg, T., Sjogren, S., Lindgren, A., and Holmberg, L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat. Med., 1: 1029-1034, 1995.
24. Artuso, M., Esteve, A., Bresil, H., Vuillaume, M., and Hall, J. The role of the ataxia telangiectasia gene in the p53-, WAF1/CIP1(p21)- and GADD45-mediated response to DNA damage produced by ionising radiation. Oncogene, 11: 1427-1435, 1995.
25. Cox, L. S., and Lane, D. P. Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays, 17: 501-508, 1995.
26. Ribeiro, U. J., Finkelstein, S. D., Safatle-Ribeiro, A. V., Landreneau, R. J., Clarke, M. R., Bakker, A., Swalsky, P. A., Gooding, W. E., and Posner, M. C. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer (Phila.), 83: 7-18, 1998.
27. Prendergast, N. J., Atkins, M. R., Schatte, E. C., Paulson, D. F., and Walther, P. J. p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma. J. Urol., 155: 1685-1692, 1996.
28. Koch, W. M., Brennan, J. A., Zahurak, M., Goodman, S. N., Westra, W. H., Schwab, D., Yoo, G. H., Lee, D. J., Forastiere, A. A., and Sidransky, D. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J. Natl. Cancer Inst., 88: 1580-1586, 1996.
29. Wilson, G. D., Richman, P. I., Dische, S., Robinson, B., Daley, F. M., and Ross, D. A. p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. Br. J. Cancer, 71: 1248-1252, 1995.
30. Sauter, E. R., Ridge, J. A., Litwin, S., and Langer, C. J. Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer. Clin. Cancer Res., 1: 1407-1412, 1995.
31. Tan, L. K. S., and Ogden, G. R. p53 overexpression in laryngeal carcinoma is not predictive of response to radiotherapy. Oral Oncol. Eur. J. Cancer. 33: 177-181, 1997.
32. Overgaard, J., Sorensen, S. B., Stausbol-Gron, B., Hoyer, M., and Alsner, J. TP53 mutation is an independent prognostic marker for poor outcome of radiotherapy in squamous cell carcinoma of the head and neck. Int. J. Rad. Oncol. Biol. Phys., 42(1): 21, 1998.
33. Norton, A. J., Jordan, S., and Yeomans, P. Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J. Pathol., 173: 371-379, 1994.
34. Nylander, K., Stenling, R., Gustafsson, H., Zackrisson, B., and Roos, G. p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer (Phila.), 75: 87-93, 1995.
35. Brennan, J. A., Boyle, J. O., Koch, W. M., Goodman, S. N., Hruban, R. H., Eby, Y. J., Couch, M. J., Forastiere, A. A., and Sidransky, D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332: 712-717, 1995.
36. Mineta, H., Borg, A., Dictor, M., Wahlberg, P., and Wennerberg, J. Correlation between p53 mutation and cyclin D1 amplification in head and neck cancer. Oral. Oncol. Eur. J. Cancer, 33: 42-46, 1997.
37. Kropveld, A., Rozemuller, E. H., Leppers, F. G., Scheidel, K. C., de Weger, R. A., Koole, R., Hordijk, G. J., Slootweg, P. J., and Tilanus, M. G. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab. Invest., 79: 347-353, 1999.
38. Lavieille, J. P., Brambilla, E., Riva-Lavieille, C., Reyt, E., Charachon, R., and Brambilla, C. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol., 115: 334-339, 1995.
39. Shin, D. M., Kim, J., Ro, J. Y., Hittelman, J., Roth, J. A., Hong, W. K., and Hittelman, W. N. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res., 54: 321-326, 1994.
40. Casey, G., Lopez, M. E., Ramos, J. C., Plummer, S. J., Arboleda, M. J., Shaughnessy, M., Karlan, B., and Slamon, D. J. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene, 13: 1971-1981, 1996.
41. Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., and Ishizaki, K. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res., 53: 368-372, 1993.
42. Dowell, S. P., and Ogden, G. R. The use of antigen retrieval for immunohistochemical detection of p53 overexpression in malignant and benign oral mucosa: a cautionary note. J. Oral Pathol. Med., 25: 60-64, 1996.
43. el-Deiry, W. S., Tokino, T., Waldman, T., Oliner, J. D., Velculescu, V. E., Burrell, M, Hill, D. E., Healy, E., Rees, J. L., Hamilton, S. R., Kinzler, K. W., and Vogelstein, B. Topological control of p21WAF1/ CIP1 expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
44. Nadal, A., Jares, P., Cazorla, M., Fernandez, P. L., SanJuan, X., Hernandez, L., Pinyol, M., Aldea, M., Mallofre, C., Muntane, J., Traserra, J., Campo, E., and Cardesa, A. p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. J. Pathol., 183: 156-163, 1997.
45. Jung, J. M., Bruner, J. M., Ruan, S., Langford, L. A., Kyritsis, A. P., Kobayashi, T., Levin, V. A., and Zhang, W. Increased levels of p21WAF1/Cip1 in human brain tumors. Oncogene, 11: 2021-2028, 1995.
46. Barboule, N., Mazars, P., Baldin, V., Vidal, S., Jozan, S., Martel, P., and Valette, A. Expression of p21WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma. Int. J. Cancer, 63: 611-615, 1995.
47. DiGiuseppe, J. A., Redston, M. S., Yeo, C. J., Kern, S. E., and Hruban, R. H. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am. J. Pathol, 147: 884-888, 1995.
48. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
49. Erber, R., Klein, W., Andl, T., Enders, C., Born, A. I., Conradt, C., Bartek, J., and Bosch, F. X. Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Int. J. Cancer, 74: 383-389, 1997.
50. Awwad, S., Jaros, E., Somes, J., and Lunec, J. p53 overexpression in head and neck carcinoma and radiotherapy results. Int. J. Radiat. Oncol. Biol. Phys., 34: 323-332, 1996.